Author

Yoshio Moriguchi

Observed names: Y Moriguchi, Y. Moriguchi, Yoshio MORIGUCHI

Observed institutions: Kyoto University, Tenri Hospital, Kyoto Medical Center, Kurashiki Central Hospital, Kyoto City Hospital, Osaka Red Cross Hospital, Kure Medical Center, Kitano Hospital

ORCID: 0000-0002-9268-5531

Observed ORCID: 0000-0002-9268-5531

OpenAlex ID: A5029147167

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants

2020 · Yukiko Inagaki-Kawata, Kenichi Yoshida, et al. · Communications Biology · 44

PDF

Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan

2013 · Hiroyasu Yamashiro, Masahiro Takada, et al. · International Journal of Clinical Oncology · 29

Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy

1993 · Seiji Yamasaki, Norimichi Kan, et al. · Breast Cancer Research and Treatment · 15

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: clinical results with a median follow-up of 26 months

2015 · Takayuki Nose, Yuki Otani, et al. · Breast Cancer · 12

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance

2015 · Yuki Otani, Takayuki Nose, et al. · Radiation Oncology · 10

PDF

Uncertainty of cosmetic evaluation after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study

2017 · Eisaku Yoden, Takayuki Nose, et al. · Japanese Journal of Radiology · 8

Clinicopathological Study in 122 Cases of Phyllodes Tumor of the Breast

2006 · Yoshio MORIGUCHI, Keiichi MISE, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 8

PDF

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 months

2022 · Ken Yoshida, Takayuki Nose, et al. · Breast Cancer · 7

Case report of a dose-volume histogram analysis of rib fracture after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study

2018 · Ken Yoshida, Yuki Otani, et al. · Journal of Contemporary Brachytherapy · 6

PDF

The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model

1994 · Takehisa Harada, Norimichi Kan, et al. · Surgery Today · 6

Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study

2022 · Yuichiro Kikawa, Takeshi Kotake, et al. · Breast Cancer · 5

PDF

Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging

2010 · Junko Ochi, Katsumi Hayakawa, et al. · Japanese Journal of Radiology · 5

A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system

1996 · Yoshio Moriguchi, Norimichi Kan, et al. · Journal of Surgical Oncology · 5

Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy

1993 · Seiji Yamasaki, Norimichi Kan, et al. · Biotherapy · 5

Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population

2021 · Noriko Senda, Nobuko Kawaguchi‐Sakita, et al. · Cancer Science · 4

SAAi gene analysis in finnish patients with AA amyloidosis

2005 · Chihiro Terai, C. P. J. Maury, et al. · 3

The synergistic antitumor effect of recombinant interleukin‐1 and low‐dose of cyclophosphamide in tumor‐bearing mice

1994 · Takehisa Harada, Norimichi Kan, et al. · Journal of Surgical Oncology · 3

OK-432-combined adoptive immunotherapy as a prognostic factor in peritoneal metastasis from gastric cancer

1994 · Keiichi Mise, Norimichi Kan, et al. · Surgery Today · 3

Two Cases of the Vascular Territory of a Single-pedicled Deep Inferior Epigastric Perforator Flap with a Vertical Midline Abdominal Scar

2020 · Daiki Morita, Toshiaki Numajiri, et al. · Plastic & Reconstructive Surgery Global Open · 1

Reduction of Tumorigenicity by an Interferon-γ-Gene-Transduced Tumor on Another Syngeneic Tumor in a Murine Model

1999 · You Ichinose, Takashi Okino, et al. · Surgery Today · 1

The effectiveness of active specific immunotherapy using interferon-γ-gene-transduced tumor cells in a murine tumor model

1997 · Yoshio Moriguchi, Norimichi Kan, et al. · Surgery Today · 1

Bone metastasis as a prognostic factor in breast cancer patients with liver metastasis given OK-432-combined adoptive immunotherapy via the hepatic artery

1993 · Norimichi Kan, Seiji Yamasaki, et al. · Biotherapy · 1

Sequential immunotherapy using interleukin-1 followed by interleukin-2 of ascitic MOPC104E-bearing mice

1993 · Takehisa Harada, Norimichi Kan, et al. · Biotherapy · 1

Multicenter development and validation of a serum microRNA–based diagnostic model for breast cancer and its association with tumor burden and biological aggressiveness: an observational case-control study

2026 · Ayane Yamaguchi, Kana Kawanishi, et al. · Breast Cancer Research

Additional file 1 of Multicenter development and validation of a serum microRNA–based diagnostic model for breast cancer and its association with tumor burden and biological aggressiveness: an observational case-control study

2026 · Ayane Yamaguchi, Kana Kawanishi, et al. · Figshare

Works count: 44

Citation count: 183

H-index: 7

I10-index: 5